Gender differences in individuals at high-risk of psychosis : a comprehensive literature review by Barajas Vélez, Ana et al.
Review Article
Gender Differences in Individuals at High-Risk of
Psychosis: A Comprehensive Literature Review
Ana Barajas,1,2,3 Susana Ochoa,3 Jordi E. Obiols,2 and Lluís Lalucat-Jo1
1Department of Research, Centre d’Higiene Mental Les Corts, Network Group for Research in Women’s Mental Health (NGRWMH),
08029 Barcelona, Spain
2Departament de Psicologia Cl´ınica i de la Salut, Facultat de Psicologia, Universitat Auto`noma de Barcelona,
Bellaterra, 08193 Cerdanyola del Valle`s, Spain
3Parc Sanitari Sant Joan de De´u, Centro de Investigacio´n Biome´dica en Red de Salud Mental (CIBERSAM),
Network Group for Research in Women’s Mental Health (NGRWMH), Sant Boi de Llobregat, 08830 Barcelona, Spain
Correspondence should be addressed to Ana Barajas; ana.barajas@chmcorts.com
Received 31 July 2014; Revised 7 December 2014; Accepted 8 December 2014
Academic Editor: Vittorio Di Michele
Copyright © 2015 Ana Barajas et al. This is an open access article distributed under the Creative Commons Attribution License,
which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.
Introduction. To date, few studies have focused on the characterization of clinical phenomenology regarding gender in population
at high-risk of psychosis. This paper is an attempt to summarize the findings found in the scientific literature regarding gender
differences in high-risk populations, taking into account parameters studied in populations with schizophrenia and other psychotic
disorders, such as incidence, clinical expression, duration of untreated illness (DUI), social functioning, and cognitive impairment
prior to full-blown psychosis development.Method. Studies were systematically searched in PubMed. Studies using gender variable
as a control variable were excluded. 12 studiesmet inclusion criteria.Results. Most of the studies found a differential pattern between
women and men as regards clinical, social, and cognitive variables in the prodromal phase, with worse performance in men except
in cognitive functioning (more severe negative symptoms, worse social functioning, and longer DUI in men). Similar conversion
rates over time were found between men and women. Conclusions. Many of the studies analyzed suggest that differences between
men and women in the expression of psychosis extend across a continuum, from the subclinical forms of illness to the debut of
psychosis. However, the small number of studies and their significant methodological and clinical limitations do not allow for firm
conclusions.
1. Introduction
Gender differences in the clinical expression and outcome
of schizophrenia and first-episode psychosis have long been
recognized in the literature on schizophrenia and other
psychoses [1–5]. Thereby, men and women experience psy-
chosis differently and often require different intervention
methods regarding doses and/or types of medications, stag-
ing of interventions, and array of treatments offered [6–8].
These studies have meant an advance in the adaptation and
improvement of therapeutic strategies targeting this popula-
tion. Taking into account gender differences found from the
dimensional perspective of psychosis, it would be reasonable
to consider different expression of the illness from early
phases of psychosis, even before the illness appears. Then,
learning whether gender differences in clinical presentation
and general functioning are present prior to the development
of psychosis is an issue of high priority because it could have
implications in intervention strategies, making it possible to
maximize the impact of these treatments taking gender into
account.
In the last two decades, scientific and clinical interest has
been focused on early identification of psychosis and inter-
vening as soon as possible to improve the illness prognosis. In
this sense, new intervention strategies have focused on people
with signs of incipient psychosis, presenting with potentially
prodromal symptoms, who have principally been categorized
into three clusters of subjects: young people with attenuated
positive symptoms, as revealed by dedicated interviews [9];
people with diagnosable transient psychotic symptoms, not
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stabilized in a syndrome yet [10, 11]; and a third category of
people with genetic risk (first degree relatives of subjects with
psychosis), or meeting the criteria for schizotypal personality
disorder, who are showing symptoms of deterioration [12].
This clinical syndrome has been termed an at-risk mental
state [13], and operationalized criteria—the ultra-high risk
(UHR) [14] or clinical high-risk (HR) criteria [15]—have been
developed to identify the syndrome.These criteria have been
adopted and adapted in a number of other settings around
the world [9]. However, this new approach has not taken into
account the gender variable, due in part to the lack of research
on this topic. To date, only a few studies have focused on the
characterization of clinical phenomenology regarding gender
in population at high-risk of psychosis.
This paper attempts to summarize the findings in the
scientific literature regarding gender differences in high-risk
populations, taking into account parameters studied in pop-
ulations with schizophrenia and other psychotic disorders,
such as incidence, clinical expression, duration of untreated
illness (DUI), social functioning, and cognitive impairment
prior to full-blown psychosis development.
In this review we will try to discuss the following
hypothesis: if gender-related factors are equally meaningful
over the entire psychosis continuum, it is reasonable to expect
that gender differences could also be already identified in
subclinical psychosis. It would then be presumed that the
same (continuous) development pattern by gender exists
from gestation of psychosis until the psychosis threshold.
Alternatively, if the hypothesized gender differences are not
found, we would have to assume that there are different
patterns in how symptoms develop in men and women, with
exponential and differential effects starting only when the
psychosis threshold is reached.
2. Method
2.1. Inclusion and Exclusion Criteria. Studies analyzing gen-
der differences in high-risk populations for psychosis were
considered.Those examining determined outcomemeasures,
such as incidence, clinical expression, duration of untreated
illness (DUI), social functioning, and cognitive impairment,
were selected. Studies using gender variable as a control
variable, in which the main aim was not to examine gender
differences in the parameters above indicated, were excluded.
2.2. Search Strategy and Study Selection. PubMed was con-
sulted twice using the following search terms and Boolean
operators up to May 31, 2014: (1) a specific search using high-
riskAND psychosisAND(genderOR sex)AND(epidemiology
OR incidence OR transition OR symptoms OR clinical OR
duration of untreated illness OR DUI OR social functioning
OR disability OR cognitive functioning OR cognitive impair-
ment OR cognition OR neurocognition), and (2) a general
search using high risk AND psychosis AND (gender OR sex).
No additional filters regarding the publication date of the
articles were used.
The general and specific PubMed searches together gen-
erated 258 hits. After removing double hits and screening
title and abstract according to the inclusion and exclusion
criteria mentioned above, 20 potentially relevant papers were
retrieved for more detailed evaluation. These studies were
screened on meeting the inclusion criteria and subsequently
12 studies were excluded after reading the full texts, due
to irrelevant subject, qualitative methodology, or descriptive
nature. Four studies cited in articles selected across PubMed,
fulfilling inclusion criteria, were also included. Finally, 12
studies met the inclusion criteria, which are included in
Table 1 and in the references list of this paper [16–27].
2.3. Data Extraction. Eligible studies were independently
screened by two researchers (S. Ochoa and A. Barajas) to
verify the fulfillment of the criteria. The following variables
were extracted to generate Table 1: (1) author and publication
data, (2) participant characteristics, (3) outcome variables,
and (4) main findings. Studies were grouped according to
whether outcomemeasures were related to the following top-
ics: epidemiology, clinical expression, social functioning, and
cognitive functioning. For each topic, a general conclusion
was extracted in order to summarize the main findings about
gender differences in high-risk populations for psychosis.
3. Results
3.1. Epidemiology: Incidence of Transition to Psychosis. His-
torically, gender differences in schizophrenia cases have been
associated with almost all aspects of the disease, including
incidence and prevalence ([28–32], see Table 2).The epidemi-
ological characteristics of a disorder can provide important
clues in the search for etiology and are essential in the
development of evidence-based treatmentmodels. No gender
differences in prevalence of schizophrenia have been found
in recent studies. Nevertheless, the most replicated result of
incidence studies is a higher rate in males versus females in
patients with schizophrenia or/and schizophrenia-like psy-
chosis. It is possible that the stricter the diagnostic criteria for
schizophrenia, the greater the exclusion for women, resulting
in a higher proportion of men diagnosed. However, other
authors have attributed this discrepancy in gender differences
between incidence and prevalence to clinical variables: a
higher suicide rate inmenwith schizophrenia comparedwith
women [5] or a higher trend to briefer episodes of psychosis,
with more complete resolution, in women [33].
According to the continuum hypothesis [34], gender-
related factors as identified in full-blown psychosis would be
equally meaningful over the entire psychosis continuum and
we should expect that “true” gender differences could also
be identified in subclinical psychosis. However, to date it is
unknown whether gender differences in the epidemiology of
schizophrenia extend to those subjects who are at high-risk
of developing psychosis. Only a few studies have addressed
this question, and they have presented inconsistent results.
In a recent study, as part of the North American Prodrome
Longitudinal Study (NAPLS) [21], gender differences in the
antecedents and course of the prodrome to psychosis in clin-
ical high-risk adolescents and young adults were analyzed.
No gender differences were found in conversion rates at
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2.5 years follow-up (26.5% women; 24.5% men). In the same
sense, Lemos-Gira´ldez et al. [18]. found that the conversion
rate to psychosis was 22.95% in the three-year follow-up
period without statistical gender differences (22.5% men
versus 23.8% women). In addition, in a study with help-
seeking adolescents at ultrahigh risk (UHR) for psychosis,
Ziermans et al. [20] showed that at the end of the follow-up
period (2 years) 15.6% of UHR adolescents had experienced
a psychotic transition, with a higher proportion of men.
Furthermore, Nordentoft et al. [17] found that, among young
adults with a diagnosis of schizotypal disorder, men had a
fourfold greater risk for conversion to schizophrenia one-
year after enrollment when compared to women. However,
the findings of this study may not be directly comparable to
the entire UHRpopulation, which includes a wider definition
of psychosis risk. To date, it is unclear if at-risk-mental-state
in men is associated with a higher risk of progression to
schizophrenia than in women. Amminger et al. [16] found
that the rate of conversion to nonaffective psychosis was not
higher amongmen thanwomen.They explained this result in
relation to the greater weight of positive psychotic symptoms
in the UHR criteria definition, whichmight be more effective
in detecting “true” prodromal cases among women than men
because they focus on positive attenuated symptoms, with
minimal attention to negative symptoms. This interpretation
is supported by Maric et al. [35], who reported that, in
a general population sample, subclinical positive psychotic
symptoms were more prevalent in women, whilst subclinical
negative psychotic symptoms were more prevalent in men.
Some epidemiological investigations that took amore general
approach concerning subclinical psychosis have detected
no gender differences [36, 37]. Van Os et al. [34] found
slightly increased odds ratios for men in a meta-analysis of
epidemiological studies focusing on subclinical psychosis.
These results referred only to prevalence rates whereas the
incidence rate in that meta-analysis was minimally higher for
women. Spauwen et al. [38] analyzed a representative Dutch
population sample (aged 17 to 28), with their main focus
being on possible gender differences before and after the age
of 21. They found that the incidence of subclinical psychotic
experiences was higher in men aged 17 to 21 but then became
similar to that of women when those men reached 22 to 28
years of age.
On the other hand, Goldstein et al. [19] demonstrated
that there are sex-specific patterns of transmission of psy-
chosis. Among fathers with psychoses most offspring who
developed psychosis were female (15.2% females versus 3.1%
males); in contrast, among mothers with psychosis 18.8%
of their male offspring developed psychosis compared with
9.5% of their daughters. So that risk of psychosis among
the offspring of parents with psychosis was dependent on
the gender variable. These results show the importance of
considering sexual differentiation in the concept of psychosis
risk.
Finally, it is important to note that more women than
men seek help for psychological or medical problems [39].
Taking this into account, additional strategies of detection
and different criteria are needed to determine real incidence
rates in risk mental states of psychosis.
The disparity found between these findings, as in the
schizophrenia studies, could be due to clinical and/or
methodological factors: the lack of consensus among the
studies in defining a patient at high-risk for psychosis, as well
as the lack of differential detection strategies according to
gender, could be some possible explanations. In this sense, in
epidemiological terms, it is not possible to confirm continuity
in gender differences between subthreshold psychosis and
frank psychosis.
In relation to the lack of consensus on the definition of
risk criteria for psychosis, they could be based on expression
differential between women and men as regards clinical,
social, and cognitive variables in the prodromal phase. We
will now turn to a summary of studies that have analyzed the
differences in clinical, functional, and cognitive expression by
gender in individuals at risk of psychosis.
3.2. Clinical Expression and DUI. Gender differences in
symptom expression have important implications for several
reasons. For example, symptom presentation likely plays
an important role in determining treatment regimens and
understanding gender differences in treatment response. To
date, the results in psychosis spectrum disorder studies
regarding this area are inconclusive ([40–47], see Table 2). A
number of factorsmay account for this, includingmedication
status (higher doses of typical antipsychotics contributing
to negative symptomatology), diagnostic stringency (use of
stricter criteria excluding women with affective symptoms),
age at onset (negative symptoms are more prominent in
younger men than in younger women), and sampling bias
(inadequate sample size or overrepresentation of men). Nev-
ertheless, the most replicated findings, in samples of patients
with psychotic spectrum disorders, suggest that affective
symptoms are more common in women while negative
symptoms tend to be more predominant in men. These
findings have also been found in some studies analyzing
gender differences in UHR samples. Willhite et al. [22]
found that, prior to the expression of full-blown psychosis,
young men were rated as having more severe negative
symptoms than women when baseline and follow-up time
points (6- and 12-month) were jointly considered. This result
is consistent with the large literature in the field, in both
studies of individuals at-risk for psychosis [23] and studies
about psychotic disorders spectrum [1, 48, 49], indicating
that the differences between men and women in clinical
presentation extend across the continuum of psychosis. Men
with UHR for psychosis had more “typical” symptoms of
schizophrenia than women. However, there was no effect
of gender for ratings on the other symptom dimensions
using the Structured Interview for Prodromal Syndromes
(SIPS). In another study analyzing individuals with UHR for
psychosis by gender [16] it was found that female gender
was one of the independent significant predictors of affective
psychosis, which is in accordance with the higher prevalence
of affective disorders in women [50]. These findings suggest
that underlying gender differences may predate the onset of
psychosis. This could reflect the fact that men and women
are vulnerable to different “types” of psychotic disorders or
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that psychosis develops differently in men and women. In
contrast, other studies of individuals with UHR for psychosis
did not find gender differences in the expression of symptoms
[18, 24]. As already mentioned in the previous section,
methodological and clinical variables could influence the
discrepancy of the results found, similarly to what occurs in
schizophrenia and first-episode psychosis studies.
In relation to onset of illness, in the ABC first-episode
sample with a broad definition of schizophrenia, Ha¨fner
[51], showed that the disorder manifests itself clearly later
in women than men, from the first sign of the illness.
Women’s mean age at first symptom was 25.4 years, 2.9 years
higher than men’s age. On the other hand, women in general
are more help seeking and have a more positive attitude
towards taking medication than men [52]. Further, women
tend to express their emotions more readily and behave in
a relatively unobtrusive way. Thus, women patients may be
more likely to be misdiagnosed, for example, with a mood
disorder [53]. Also, it is widely accepted that women have
better access to social networks and social support [54].
This behaviour pattern together with a later onset of first
symptoms of illness could indicate a shorter duration of
untreated illness in women. However, Cocchi et al. [24] and
previous studies [16, 18] with UHR samples did not find
significant differences by gender in DUI, which was shorter
in women than in men in most samples. This discrepancy
may be a consequence of faster and longer deterioration in
men when symptoms arise [18]. Additionally, in the general
population age-related gender differences in maturational
processes have been observed, in particular, a significantly
greater loss of cerebral grey matter in boys compared to girls
[55], which may represent the underlying mechanism of men
showing an earlier age of onset of psychosis than women in
subclinical samples. An alternative explanationmay be found
in the differential exposure to estrogens which may play a
protective role by decreasing the risk for and the severity
of psychotic disorders in women [56]. Despite the results
about DUI being replicated in UHR samples, we must take
into account that a high percentage of the sample will not
transition to psychosis. So the implications of these findings
in the continuumof psychosis should be treated with caution.
These findings should be compared with studies about UHR
individuals who convert to psychosis.
Regarding the association between clinical symptoms and
social functioning found in psychotic disorders [57, 58],
there are studies with UHR samples which confirm that this
association is already present before the onset of psychosis
[22, 23]. Because UHR patients may experience different
combinations of symptoms according to gender these dif-
ferences may contribute to different functional outcomes.
Based on these results, developing targeted intervention to
decrease the severity of symptoms would improve the general
functioning and quality of life for patients.
3.3. Social Functioning. In general, psychosis spectrumdisor-
der studies analyzing premorbid and social functioning show
better performance in women ([45, 59–63], see Table 2). We
have not found studies reporting worse social functioning
in women. However, there are studies reflecting the absence
of gender differences in this area ([47, 64], see Table 2).
Methodological issuesmight explain these discrepancies (i.e.,
small sample size, lack of sample-gender representativeness,
or measures used to assess social functioning). Similar con-
clusions can be drawn from studies with patients at high-
risk for psychosis. Willhite et al. [22] investigated gender
differences in functioning and social support in individuals
at UHR for developing a psychotic disorder, showing that
men had marginally lower functioning than women over
the three time points (at baseline, 6- and 12-month follow-
up). Differences in other psychosocial factors may also
contribute to better functioning in women UHR patients.
Women reported higher levels of social support at baseline:
women were more likely to say that their friends and family
members “appreciate them” and that they feel they can “open
up” to their friends and family members, while men report
marginally higher levels of criticism than women. These
results would support the importance of psychosocial inter-
ventions for this population. However, subsequently, mixed
results have been obtained, from studies that contradict these
results [18] as well as those that confirm them [25].
In relation to premorbid functioning, most studies in
psychotic disorder samples have found gender differences,
this being worse in men than in women [44, 46, 65].
Contrary to expectation, the NAPLS study [21] found that
early childhood academic, social, and total adjustments were
comparable by gender. It is possible that impairment at this
agemay be too subtle to be detected, beingmore evident from
adolescence.
On the other hand, there are suggestions that deficits
in social functioning are often predictors of later social
functioning [66]. Besides, prior findings have indicated that
social and role (school/work) functioning are key predic-
tors of conversion among UHR youth [67, 68]. Therefore,
prevention strategies could be improved with a more com-
prehensive approach that involves developmentally earlier
functional deficits. However, it has been suggested that
social functioning as a predictor of psychosis onset may
be stronger for men than women [22, 26]. These findings
are corroborated in Walder et al. [21]; specifically, poorer
baseline social functioning and positive prodromal symp-
toms predict greater conversion risk among men. So, to
understand the early development of psychosis it is essential
to consider sexually differentiated predictors. It may be
helpful to improve risk identification using algorithms that
take into account the gender variable. To date a global
assessment of functioning (GAF) score of 50 or below has
been used in the risk criteria, but gender variable was not
considered.
There is some agreement among the results found in
the scientific literature about full-blown psychosis and the
UHR studies regarding social and role functioning. These
results support the continuumhypothesis in the development
of psychosis, taking into account a differential expression
of social functioning according to gender from premorbid
phases, which is worse inmen. Nevertheless, broader samples
with more equal distribution by gender are essential for more
rigorous investigation.
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3.4. Cognitive Functioning. Although studies analyzing cog-
nitive function in patients with psychosis spectrum disor-
ders have reported gender differences on neuropsychological
testing ([69–72], see Table 2), these differences have not
been tested in all studies ([73, 74], see Table 2) and their
nature is controversial. As indicated in previous sections,
these discrepancies could be partly related to methodological
issues. Among studies showing gender differences, the find-
ing most often replicated indicates higher levels of cognitive
functioning in women.
Over the past several years, under the assumption that
the prodromal period is marked by disruptions in the
normal brain maturation processes having an impact on
neurocognition, there has been an accumulation of data
examining cognition in those at elevated risk for psychosis
[75–77], which have confirmed that cognitive deficits are
already present before the first episode. These studies report
widespread cognitive deficits intermediate to healthy control
and first-episode psychosis samples. However, these studies
have several methodological limitations (i.e., small samples,
lack of power to detect differences, and a limited longitu-
dinal framework, among others) that make it difficult to
generalize the results. In this sense more research about
cognition functioning is required, also taking into account
gender factor from the incipient phases of psychosis. To
date, scarce research has been performed in this direction.
To our knowledge, the study of Walder et al. [27] is the
only one to consider this issue as a main objective. It
is a longitudinal study of 37 adolescents at high-risk for
psychosis, which showed thatwomenwho convert performed
worse on several neurocognitive measures than same-gender
subjects who do not convert. There were no significant
differences between men converters and nonconverters. In
the group who converts, women showed worse performance
than their high-riskmale counterparts on ameasure of verbal
memory, unlike the results foundwith schizophrenia patients
[71]. The low number of women converters did not allow
for valid conclusions on gender differences. Nevertheless,
these results suggest the importance of considering sexually
differentiated patterns of cognitive decline in prodromal
individuals. Furthermore, sexually differentiated neurohor-
monal fluctuations are present during adolescence and early
adulthood and may play an integral role in the transition to
psychosis [78].
More studies are needed to explore a possible continuity
of cognitive decline according to gender from subthreshold
phases of psychosis up to its onset. Future longitudinal
research, overcoming the previous methodological limita-
tions and aimed at tracking at-risk cohorts from premorbid
periods until clinical high-risk to psychosis onset, will help
clarify the existence of neurocognitive profiles in predicting
conversion risk based on gender differences.
4. Conclusions
In conclusion, although the extent of gender differences in
individuals with UHR for psychosis is reduced mainly due
to the small number of studies published to date and their
limitations (see Section 5), in this section we will try to
summarize the most relevant findings and their clinical and
research implications.
(i) Inconsistent results were found in relation to transi-
tion to psychosis: some studies did not show gender
differences and others indicated a greater risk for
conversion to psychosis inmen. It might be suggested
that differential precipitating factors exist according
to gender which are involved in conversion to psy-
chosis and their identification should be useful in
clinical practice.
(ii) Men at-risk for psychosis have more severe negative
symptoms than women before full-blown psychosis,
beingmore difficult to detect them across current risk
criteria for psychosis focused on positive attenuated
symptoms. In addition, developing targeted interven-
tion to decrease the severity of negative symptoms
during prodromal phase, more severe in men, would
improve the general functioning and quality of life for
patients since earlier phases of psychosis.
(iii) Female gender is one of the independent signifi-
cant predictors of affective psychosis. It highlights
the importance of considering sexually differentiated
high-risk criteria to improve the identification of
possible risk cases with different diagnoses in the
continuum of psychosis.
(iv) Significant gender differences have not been found in
DUI, although it is shorter in women than in men in
most of the studies. It is likely that more women seek
help for psychological ormedical problems thanmen.
Additional detection strategies, especially targeted at
males, should be developed, not only to improve the
quality of research but also above all to prevent the
development of more severe forms of the disease.
(v) Men show lower functioning and social support
than women before full-blown psychosis. Also, social
functioning is a stronger predictor of psychosis onset
in men than women. Psychosocial interventions tar-
geted at this population would be helpful to improve
the prognosis of the illness.
(vi) The limited scientific evidence about cognitive
impairment in prodromal phase according to gender
has indicated a differential sex effect that varies by
risk status. However, the lack of studies does not
allow us to generalize from the results. It is necessary
to broaden our knowledge in this area and so be able
to implement the findings in clinical practice.
In summary, many of the studies analyzed suggest that
differences between men and women in the expression of
psychosis extend across a continuum, from the subclinical
forms of illness to the debut of psychosis, mainly in aspects of
clinical expression (such as more negative symptoms inmen)
and social functioning (such as premorbid and psychosocial
functioning, worse in men). However, the small number
of studies and their significant methodological and clinical
limitations do not allow for firm conclusions.
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5. Limitations and Future Directions
Wemust be cautious when considering the extracted conclu-
sions of this comprehensive review about gender differences
in individuals at high-risk for psychosis due to the limitations
of the studies analyzed.Themain clinical andmethodological
limitations of the studies included in this review are the
following: (a) the limited sample size with unequal distri-
bution of participants at baseline by gender, (b) a strict age
range, (c) the exclusion of people with substance dependence,
(d) the lack of standardized instruments to measure some
variables (e.g., DUI), (e) the use of diagnostic criteria for
the UHR which require the presence of symptoms in excess,
and (f) the large attrition rates. Taking into account these
limitations, it is possible that the samples of these studies are
not representative of the population of all UHR cases andmay
obscure or reduce the extent of gender-related differences
found. Also, the methodological variability of these studies
limits the generalizability of their findings. Nevertheless,
something to keep in mind is that gender differences might
be less evident in UHR samples than in samples of people
diagnosed with psychotic disorders because only a minority
of UHR people develops full-blown psychosis [79].
More research is needed to overcome the limitations
mentioned in order to deepen our knowledge about this
topic. Future researchers should be focused on (a) improving
detection algorithms for risk of psychosis, due to differential
expression of subclinical forms of psychosis according to gen-
der; according to the results found, there is a need to include
negative symptoms in the risk criteria, which may help to
identify more young men at risk for psychosis; (b) analyzing
other variables or risk factors by gender such as substance use,
family history, stress, or obstetric complications; (c) using
gender as a covariable in future research about effectiveness
of interventions in prodromal phase; (d) studying gender
differences in the precipitating factor for psychosis; (e) ana-
lyzing different pattern of cognitive impairment by gender;
and (f) identifying protector factors delaying conversion by
gender. Further elucidation of differential pattern by gender
during the prodrome to psychosis is critical to understanding
illness etiology and generating more powerful predictive
models that would be maximally sensitive and specific. This
may aid in development of individually tailored treatments,
with consideration of the effects of gender, which may tar-
get different neurobiological systems and/or use alternative
cognitive/behavioral approacheswith optimal effect. Gender-
sensitive services are a first step toward individual-specific
personalized care, as men and women may differentially
benefit from certain approaches to intervention.
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